SCHEMBL24326864

SCHEMBL24326864

c1ccc(-c2c3ccccc3c(-c3cccc(-c4cccc(-n5c6ccc7ccccc7c6c6c7cc8ccccc8cc7ccc65)c4)c3)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.38
ESR2 Q92731 6/20 0.38
NQO2 P16083 2/20 0.35
ALDH1A1 P00352 1/20 0.33
HIF1A Q16665 1/20 0.33
CYP1B1 Q16678 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PDE10A Q9Y233 1/20 0.33
ALOX5 P09917 1/20 0.33
CYP1A2 P05177 3/20 0.32
ERBB2 P04626 2/20 0.32
FYN P06241 2/20 0.32
AHR P35869 2/20 0.32
MAOA P21397 1/20 0.32
ACHE P22303 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
EGFR P00533 1/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14650057 0.91 KDM4E (0.38) ESR1ESR2NQO2ALDH1A1CYP1B1
SCHEMBL24326558 0.88 ESR1 (0.40) ESR1ESR2NQO2ALDH1A1HIF1A
SCHEMBL14650123 0.88 NQO2 (0.43) NQO2ALDH1A1HIF1ACYP1B1HSD17B10
SCHEMBL24326863 0.87 ESR1 (0.39) ESR1ESR2NQO2ALDH1A1HIF1A
SCHEMBL24326596 0.86 SOS1 (0.34) ESR1ESR2NQO2ALDH1A1HIF1A
SCHEMBL14650122 0.85 HSD17B1 (0.38) ESR1ESR2NQO2CYP1B1ALOX5
SCHEMBL24326886 0.85 ESR1 (0.36) ESR1ESR2NQO2ALDH1A1HIF1A
SCHEMBL14650085 0.84 ESR1 (0.41) ESR1ESR2NQO2ALOX5CYP1A2
SCHEMBL24326595 0.83 CA12 (0.35) ESR1ESR2PDE10AALOX5CYP1A2
SCHEMBL24326555 0.83 KDM4E (0.36) ESR1ESR2ALOX5CYP1A2ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220123231-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, Display Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220123231-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, Display Device, and Lighting Device SUN2, CRY2, NBAS ESR1 225/4885ESR2 774/4885NQO2 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.